Soros Capital Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Soros Capital Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-364,824	Closed	-$343K	–	59
2025 Q4	$343K	Hold	364,824	–	–	0.09%	54
2025 Q3	$109K	Hold	364,824	–	–	0.03%	60
2025 Q2	$95.8K	Hold	364,824	–	–	0.03%	51
2025 Q1	$13.9K	Hold	364,824	–	–	﹤0.01%	50
2024 Q4	$65.7K	Hold	364,824	–	–	0.01%	64
2024 Q3	$51.1K	Hold	364,824	–	–	0.01%	52
2024 Q2	$37.2K	Hold	364,824	–	–	0.02%	45
2024 Q1	$66.6K	Hold	364,824	–	–	0.01%	41
2023 Q4	$120K	Buy	+364,824	New	+$163K	0.09%	29

Other funds holding RVMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Soros Capital Management's RVMDW Position: Q1 2026 in Review

Soros Capital Management sold out of Revolution Medicines Inc Warrant (RVMDW) in Q1 2026, closing a stake of 364,824 shares — an estimated $343K sold.

Soros Capital Management first reported a position in RVMDW in Q4 2023 and held it in 9 quarters. The position peaked at $343K in Q4 2025. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

Soros Capital Management reported no remaining Revolution Medicines Inc Warrant position as of Q1 2026 after selling out during the quarter.
Soros Capital Management sold 364,824 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $343K.
Soros Capital Management first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and held it in 9 quarters.
Soros Capital Management's Revolution Medicines Inc Warrant position peaked at $343K in Q4 2025.
23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Soros Capital Management's 13F filing for Q1 2026, filed 15 May 2026.